ACR Convergence 2020

November 5-9, 2020. All Virtual.

View by Number View by Title View Sessions

View by Date

Monday, November 9, 2020

9:00AM-11:00AM: Abstract Number: 1664

Walking Energetics, Fatigue, and Physical Activity in People with Knee Osteoarthritis

Osteoarthritis – Clinical Poster II

9:00AM-11:00AM: Abstract Number: 1663

Walking for Exercise May Be Symptom and Structure Modifying for Those with Established OA and with Varus Alignment – Data from the Osteoarthritis Initiative

Osteoarthritis – Clinical Poster II

9:00AM-11:00AM: Abstract Number: 1737

What Influences Fatigue Improvement in Rheumatoid Arthritis? A Prospective Cohort Study

RA – Diagnosis, Manifestations, & Outcomes Poster IV: Lifespan of a Disease

9:00AM-11:00AM: Abstract Number: 1934

What Is the Significance of Periarterial Temporal Small Vessel Inflammation (SVI) on Temporal Artery Biopsy (TAB) in the Diagnosis of Vasculitis? A Systematic Review and Meta-analysis

Vasculitis – Non-ANCA-Associated & Related Disorders Poster II

9:00AM-11:00AM: Abstract Number: 1599

Workflows for Collecting and Using Patient-reported Outcomes Across Rheumatology Practices

Measures & Measurement of Healthcare Quality Poster

9:00AM-11:00AM: Abstract Number: 1773

Worse Maternal and Fetal Outcomes Among Hospitalized U.S. Pregnant Women with Systemic Lupus Erythematosus (SLE) and Rheumatoid Arthritis (RA)

Reproductive Issues in Rheumatic Disorders Poster

10:00AM-10:50AM: Abstract Number: 2046

Alterations in Circulating CD4+ T Cell Phenotypes in CCP+ Early RA and CCP+ At-risk Individuals by Mass Cytometry

T Cell Biology & Targets in Autoimmune & Inflammatory Disease (2043–2047)

10:00AM-10:50AM: Abstract Number: 1993

Cardiovascular Risk in Rheumatoid Arthritis Patients Treated with Methotrexate versus Hydroxychloroquine

RA – Treatments I: Maximizing Health in RA (1993–1997)

10:00AM-10:50AM: Abstract Number: 1984

Causal Pathways to Health-Related Quality of Life in Children with Juvenile Idiopathic Arthritis: Results from the ReACCh-Out Cohort

Pediatric Rheumatology – Clinical II: Outcomes & Care Delivery (1983–1987)

10:00AM-10:50AM: Abstract Number: 2044

Complex, Dynamic Attributes of Antigen-specific T Cells in Rheumatoid Arthritis

T Cell Biology & Targets in Autoimmune & Inflammatory Disease (2043–2047)

10:00AM-10:50AM: Abstract Number: 1960

Cost-effectiveness of Surgical and Non-Surgical Weight Loss Programs for Morbidly Obese Patients with Knee Osteoarthritis

Health Services Research (1958–1962)

10:00AM-10:50AM: Abstract Number: 1961

Decreased Visits in RISE Practices Due to the SARS-CoV-2 Global Pandemic

Health Services Research (1958–1962)

10:00AM-10:50AM: Abstract Number: 1986

Determinants of Variation in Pediatric Systemic Lupus Erythematosus Care Delivery

Pediatric Rheumatology – Clinical II: Outcomes & Care Delivery (1983–1987)

10:00AM-10:50AM: Abstract Number: 1959

Epidemiology of Hospitalizations and Associated Mortality in Vasculitis: A National Study

Health Services Research (1958–1962)

10:00AM-10:50AM: Abstract Number: 1996

Evaluation of Response to Pneumococcal Vaccination in Patients with Rheumatoid Arthritis Receiving Upadacitinib: Results from a Phase 2 Open-Label Extension Study

RA – Treatments I: Maximizing Health in RA (1993–1997)

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].